professor stephen nicholls comparing different approaches to pcsk9 inhibition
Published 7 years ago • 75 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
5:38
does pcsk9 inhibition impact atherosclerosis? | professor steve nicholls
-
1:06
professor stephen nicholls following fourier what is the role of ezetimibe in the management of ver
-
1:12
prof. s. nicholls: patient progress despite very low ldl cholesterol levels on a pcsk9 inhibitor
-
0:43
professor stephen nicholls are very low ldl cholesterol levels safe
-
1:01
professor stephen nicholls can we use imaging to define very high risk patients
-
1:08:18
lipoprotein(a) in coronary disease: an emerging novel target (steven e nissen, md) february 14, 2019
-
26:14
professor steven nissen - lipoprotein(a): a new target for therapeutic intervention
-
1:01:03
new lipid lowering therapies a practical deep dive
-
3:21
prof. stephen nicholls tg targeted therapy, from the floor at eas congress 2019
-
1:30:04
the sir john monash lecture - professor stephen nicholls
-
3:40
esc congress 2015 buzz: novel ldl lowering treatments | professor steve nicholls
-
23:18
professor kausik ray - pcsk9 inhibition – have we reached the limits of lipid lowering and outcome?
-
3:41
sirna pcsk9 therapeutics clinical perspectives | professor steve nicholls
-
4:12
esc 2017: the glagov trial - stephen nicholls
-
52:04
a real world approach to ldl cholesterol using pcsk9 inhibitors, october 5 2018
-
17:23
lipidology
-
1:59
update of clinical guidance for use of pcsk9 inhibitors 2017
-
1:03:46
pcsk9 inhibitors within the targeted treatment approach to hypercholesterolemia 4/26/16
-
18:00
what's new on the lipid management landscape? the experts compare notes
-
6:46
pcsk9 inhibitors: how do we weigh up the benefit versus cost of treatment
-
40:02
racp congress 2017 – cottrell memorial lecture, professor stephen nicholls
-
58:16
medicine grand rounds 3-19-19